AzurRx SAS
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 2 Combination Study With Escalating Doses of MS1819-SD on Top of a Stable Dose of PPEs (NCT04302662) | AzurRx SAS | 2019-06-27 |
Track AzurRx SAS automatically
Every clearance here is in the API, with alerts when new ones post.